Skip to main content

Table 1 Data points abstracted from selected studies [11].

From: Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review

a) Countries where the systems operate
b) The extent of data collection (e.g. community services, facilities services)
c) The main purpose of the system d) Records linkage
e) The level of implementation (e.g. local, national)
f) Target population (e.g. specified subgroups or total population)
g) The data collection form used (e.g. electronic, paper)
h) Whether the data entered into the registry was primary data, or if the registry was based on secondary data from pre-existing sources.
i) MNCHcare periods that the system registers
j) Whether it collects the MNCH variables defined by the GAIA project
k) Whether it collects socio-demographic data, obstetric information, pre-existing conditions of each women, and antenatal care outcome process.
l) Type of code for classification of diseases used
m) The individual data capture process (how and where it is done)
n) Baseline data (pregnancy and outcomes) timeframe
o) Capability to import, compile and export electronic data.
p) Capability to link individual MNCH data with other registers(e.g. laboratory records, expense drug records, vaccine registers)
q) Type of monitoring to assess data quality
r) Whether it has a back-up policy.
s) Availability of data collection tools and system documentation
t) Maintenance and update process
u) Whether it has data access policies,
v) Type of privacy protection
w) Funding or sponsor of each system
x) Prior use in active surveillance or pharmacovigilance or post-marketing surveillance.